1. Market Research
  2. > Apotex Inc. - Strategic SWOT Analysis Review

Apotex Inc. - Strategic SWOT Analysis Review

  • February 2016
  • -
  • Global Data
  • -
  • 33 pages

Apotex Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Apotex Inc. (Apotex) is a pharmaceutical company that carries out the production and marketing of a wide range of generic pharmaceuticals. It also undertakes the research, development, manufacturing and distribution of non-prescription and private label medicines, fine chemicals and disposable plastics for medicinal use. The company focuses on providing an array of affordable medicines to patients, healthcare providers, payers and governments worldwide. The company operates through affiliates in Canada, Mexico, the US, Belgium, Czech Republic, the Netherlands, Poland, Spain, Australia, India, New Zealand, Saudi Arabia and Turkey

Apotex Inc. Key Recent Developments

Oct 15,2015 Federal Court judge slams Conservative Government and Minister of Health in the Apotex Judgment
Mar 16,2015 Apotex announces realignment and executive leadership team to better serve the healthcare market in Canada and globally
Jan 30,2015 FDA Issues Warning Letter To Apotex Research

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Table Of Contents

Apotex Inc. - Strategic SWOT Analysis Review
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1 - About the Company 6
Apotex Inc. - Key Facts 6
Apotex Inc. - Key Employees 7
Apotex Inc. - Key Employee Biographies 8
Apotex Inc. - Major Products and Services 9
Apotex Inc. - Pharmaceutical Pipeline Products Data 11
Apotex Inc., Pipeline Products by Therapy Area 11
Apotex Inc., Pipeline Products by Development Phase 12
Apotex Inc. - History 14
Apotex Inc. - Company Statement 17
Apotex Inc. - Locations And Subsidiaries 18
Head Office 18
Other Locations and Subsidiaries 18
Section 2 - Company Analysis 20
Apotex Inc. - Business Description 20
Apotex Inc. - Corporate Strategy 21
Apotex Inc. - SWOT Analysis 22
SWOT Analysis - Overview 22
Apotex Inc. - Strengths 22
Strength - Dominant Market Position 22
Strength - Global Network 22
Strength - Strong In-house Research Capabilities 22
Apotex Inc. - Weaknesses 23
Weakness - Product Recalls 23
Apotex Inc. - Opportunities 24
Opportunity - Resuming Shipping to the US 24
Opportunity - Strategic Initiatives 24
Apotex Inc. - Threats 25
Threat - Stringent Government Regulations 25
Threat - Competitive Generic Drug Market 25
Threat - Uncertain RandD Outcomes 25
Apotex Inc. - Key Competitors 26
Section 3 - Company's Lifesciences Financial Deals and Alliances 27
Apotex Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 27
Apotex Inc., Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 28
Apotex Inc., Recent Deals Summary 29
Section 4 - Company's Recent Developments 30
Oct 15, 2015: Federal Court judge slams Conservative Government and Minister of Health in the Apotex Judgment 30
Mar 16, 2015: Apotex announces realignment and executive leadership team to better serve the healthcare market in Canada and globally 31
Jan 30, 2015: FDA Issues Warning Letter To Apotex Research 32
Section 5 - Appendix 33
Methodology 33
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
Apotex Inc., Key Facts 6
Apotex Inc., Key Employees 7
Apotex Inc., Key Employee Biographies 8
Apotex Inc., Major Products and Services 9
Apotex Inc., Number of Pipeline Products by Therapy Area 11
Apotex Inc., Number of Pipeline Products by Development Stage 12
Apotex Inc., Pipeline Products By Therapy Area and Development Phase 13
Apotex Inc., History 14
Apotex Inc., Other Locations 18
Apotex Inc., Subsidiaries 18
Apotex Inc., Key Competitors 26
Apotex Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 27
Apotex Inc., Pharmaceuticals and Healthcare, Deals By Type, 2010 to YTD 2016 28
Apotex Inc., Recent Deals Summary 29

List of Figures
Apotex Inc., Pipeline Products by Therapy Area 11
Apotex Inc., Pipeline Products by Development Phase 12
Apotex Inc., Pharmaceuticals and Healthcare, Deals By Year, 2010 to YTD 2016 27
Apotex Inc., Pharmaceuticals and Healthcare, Deals by Type, 2010 to YTD 2016 28

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.